FINE FOODS & PHARMACEUTICALS (FF.MI) Stock Fundamental Analysis
Europe - BIT:FF - IT0005215329 - Common Stock
9.24 EUR
+0.56 (+6.45%)
We assign a fundamental rating of 5 out of 10 to FF. FF was compared to 20 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of FF get a neutral evaluation. Nothing too spectacular is happening here. FF is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year FF was profitable.
In the past year FF had a positive cash flow from operations.
In multiple years FF reported negative net income over the last 5 years.
Of the past 5 years FF 4 years had a positive operating cash flow.
1.2 Ratios
FF has a Return On Assets of 5.41%. This is in the better half of the industry: FF outperforms 77.78% of its industry peers.
The Return On Equity of FF (9.93%) is better than 72.22% of its industry peers.
The Return On Invested Capital of FF (9.48%) is better than 77.78% of its industry peers.
FF had an Average Return On Invested Capital over the past 3 years of 3.16%. This is below the industry average of 7.27%.
The 3 year average ROIC (3.16%) for FF is below the current ROIC(9.48%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.41% | ||
| ROE | 9.93% | ||
| ROIC | 9.48% |
ROA(3y)-0.42%
ROA(5y)0.94%
ROE(3y)-1.24%
ROE(5y)0.96%
ROIC(3y)3.16%
ROIC(5y)3.16%
1.3 Margins
With a Profit Margin value of 3.61%, FF is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
With a Operating Margin value of 6.50%, FF is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
FF's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 32.54%, FF is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of FF has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.5% | ||
| PM (TTM) | 3.61% | ||
| GM | 32.54% |
OM growth 3Y24.97%
OM growth 5Y2.12%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.32%
GM growth 5Y2.27%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so FF is still creating some value.
The number of shares outstanding for FF remains at a similar level compared to 1 year ago.
Compared to 5 years ago, FF has more shares outstanding
The debt/assets ratio for FF has been reduced compared to a year ago.
2.2 Solvency
FF has an Altman-Z score of 3.24. This indicates that FF is financially healthy and has little risk of bankruptcy at the moment.
FF has a better Altman-Z score (3.24) than 61.11% of its industry peers.
FF has a debt to FCF ratio of 4.90. This is a neutral value as FF would need 4.90 years to pay back of all of its debts.
FF has a Debt to FCF ratio of 4.90. This is in the better half of the industry: FF outperforms 72.22% of its industry peers.
A Debt/Equity ratio of 0.27 indicates that FF is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.27, FF belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 4.9 | ||
| Altman-Z | 3.24 |
ROIC/WACC1.16
WACC8.2%
2.3 Liquidity
A Current Ratio of 1.36 indicates that FF should not have too much problems paying its short term obligations.
With a Current ratio value of 1.36, FF is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
A Quick Ratio of 0.91 indicates that FF may have some problems paying its short term obligations.
With a Quick ratio value of 0.91, FF is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
FF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1893.44%, which is quite impressive.
FF shows a decrease in Revenue. In the last year, the revenue decreased by -3.85%.
Measured over the past years, FF shows a quite strong growth in Revenue. The Revenue has been growing by 8.83% on average per year.
EPS 1Y (TTM)1893.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.26%
Revenue 1Y (TTM)-3.85%
Revenue growth 3Y7.75%
Revenue growth 5Y8.83%
Sales Q2Q%-3.92%
3.2 Future
The Earnings Per Share is expected to grow by 26.27% on average over the next years. This is a very strong growth
Based on estimates for the next years, FF will show a quite strong growth in Revenue. The Revenue will grow by 12.10% on average per year.
EPS Next Y35.61%
EPS Next 2Y31.63%
EPS Next 3Y27.28%
EPS Next 5Y26.27%
Revenue Next Year6.76%
Revenue Next 2Y10.32%
Revenue Next 3Y10.11%
Revenue Next 5Y12.1%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 13.59, the valuation of FF can be described as correct.
94.44% of the companies in the same industry are more expensive than FF, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.86, FF is valued rather cheaply.
A Price/Forward Earnings ratio of 14.13 indicates a correct valuation of FF.
Based on the Price/Forward Earnings ratio, FF is valued cheaply inside the industry as 94.44% of the companies are valued more expensively.
FF's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.59 | ||
| Fwd PE | 14.13 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FF indicates a rather cheap valuation: FF is cheaper than 100.00% of the companies listed in the same industry.
FF's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. FF is cheaper than 72.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.33 | ||
| EV/EBITDA | 6.07 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FF's earnings are expected to grow with 27.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y31.63%
EPS Next 3Y27.28%
5. Dividend
5.1 Amount
FF has a Yearly Dividend Yield of 1.59%.
FF's Dividend Yield is rather good when compared to the industry average which is at 0.71. FF pays more dividend than 94.44% of the companies in the same industry.
FF's Dividend Yield is slightly below the S&P500 average, which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.59% |
5.2 History
The dividend of FF has a limited annual growth rate of 4.24%.
Dividend Growth(5Y)4.24%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
22.40% of the earnings are spent on dividend by FF. This is a low number and sustainable payout ratio.
The dividend of FF is growing, but earnings are growing more, so the dividend growth is sustainable.
DP22.4%
EPS Next 2Y31.63%
EPS Next 3Y27.28%
BIT:FF (10/3/2025, 7:00:00 PM)
9.24
+0.56 (+6.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners12.42%
Inst Owner ChangeN/A
Ins Owners53.17%
Ins Owner ChangeN/A
Market Cap203.83M
Analysts85.45
Price Target12.31 (33.23%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.59% |
Yearly Dividend0.12
Dividend Growth(5Y)4.24%
DP22.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.26%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.67%
EPS NY rev (3m)1.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.59 | ||
| Fwd PE | 14.13 | ||
| P/S | 0.56 | ||
| P/FCF | 18.33 | ||
| P/OCF | 4.45 | ||
| P/B | 1.54 | ||
| P/tB | 1.71 | ||
| EV/EBITDA | 6.07 |
EPS(TTM)0.68
EY7.36%
EPS(NY)0.65
Fwd EY7.08%
FCF(TTM)0.5
FCFY5.46%
OCF(TTM)2.08
OCFY22.49%
SpS16.49
BVpS5.99
TBVpS5.39
PEG (NY)0.38
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.41% | ||
| ROE | 9.93% | ||
| ROCE | 13.75% | ||
| ROIC | 9.48% | ||
| ROICexc | 10.67% | ||
| ROICexgc | 11.67% | ||
| OM | 6.5% | ||
| PM (TTM) | 3.61% | ||
| GM | 32.54% | ||
| FCFM | 3.06% |
ROA(3y)-0.42%
ROA(5y)0.94%
ROE(3y)-1.24%
ROE(5y)0.96%
ROIC(3y)3.16%
ROIC(5y)3.16%
ROICexc(3y)3.64%
ROICexc(5y)4.57%
ROICexgc(3y)4.02%
ROICexgc(5y)5.02%
ROCE(3y)4.59%
ROCE(5y)4.62%
ROICexcg growth 3Y13.05%
ROICexcg growth 5Y-1.19%
ROICexc growth 3Y17.44%
ROICexc growth 5Y-2.63%
OM growth 3Y24.97%
OM growth 5Y2.12%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.32%
GM growth 5Y2.27%
F-Score7
Asset Turnover1.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 4.9 | ||
| Debt/EBITDA | 0.91 | ||
| Cap/Depr | 220.17% | ||
| Cap/Sales | 9.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 116.33% | ||
| Profit Quality | 84.79% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 3.24 |
F-Score7
WACC8.2%
ROIC/WACC1.16
Cap/Depr(3y)145.26%
Cap/Depr(5y)138.08%
Cap/Sales(3y)9.82%
Cap/Sales(5y)9.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1893.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.26%
EPS Next Y35.61%
EPS Next 2Y31.63%
EPS Next 3Y27.28%
EPS Next 5Y26.27%
Revenue 1Y (TTM)-3.85%
Revenue growth 3Y7.75%
Revenue growth 5Y8.83%
Sales Q2Q%-3.92%
Revenue Next Year6.76%
Revenue Next 2Y10.32%
Revenue Next 3Y10.11%
Revenue Next 5Y12.1%
EBIT growth 1Y87.96%
EBIT growth 3Y34.65%
EBIT growth 5Y11.14%
EBIT Next Year132.69%
EBIT Next 3Y46.53%
EBIT Next 5Y31.96%
FCF growth 1Y3472.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y147.33%
OCF growth 3YN/A
OCF growth 5Y19.07%